EHC

Encompass Health Corp

Halal Rating :
Comfortable
Last Price $98.3
Market Cap $10.0b
1D Change

0.0 %

1 Year Change

38.43 %

Next Earnings Date

Yet to be announced

Company Overview

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. As of April 11, 2022, it operated 147 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico.

Revenue Sources

Pass

Based on review of Encompass Health's SEC filings and financial statements, the company's revenue is primarily derived from post-acute healthcare services, including inpatient rehabilitation and home health services. These are all halal healthcare services that provide clear value to patients. The company does not derive revenue from any haram sources like alcohol, gambling, or other prohibited activities.

Reliance on Interest

Pass
Reporting Date Total Revenue Total Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $1.35b $1.18b - $35.3m 0.00% 3.00%
June 30, 2024 $1.3b $1.12b - $34.3m 0.00% 3.06%
March 31, 2024 $1.32b $1.14b - $35.2m 0.00% 3.08%
Dec. 31, 2023 $1.25b $1.09b - $34.9m 0.00% 3.20%

Analyzing the last four quarters of financial data, the company's interest expense relative to total expenses has remained consistently low. Interest expense represented approximately 3% of total expenses across all quarters examined, which is below concerning levels for a capital-intensive healthcare operation.

Operational Ethics

Pass

Based on review of company documents and public information, Encompass Health operates primarily in the United States and does not have significant operations or partnerships with entities in Israel or associations with the Chinese Communist Party. No evidence was found of material ongoing relationships with known human rights violators.

Rating Justification

Member Vote

Agree: 0 Disagree: 0

Login to vote on this

Comments

0 Comments

Login to join the discussion

Recent News & Updates